Rubius Therapeutics Raises $100 Million in Crossover Financing Post author:Sam Post published:February 28, 2018 Post category:BioPharma Rubius Therapeutics has closed on an oversubscribed $100 million crossover financing. Source: BioSpace You Might Also Like Certara Corporation Releases New Version Of D360, Its Industry-Leading Informatics Platform For Pharma Discovery Scientists January 30, 2017 Unknown Group of Traders Earned $4.9M Before Sanofi-Bioverativ Deal January 29, 2018 Merck & Co. Terminates Hep C Development Programs September 28, 2017
Certara Corporation Releases New Version Of D360, Its Industry-Leading Informatics Platform For Pharma Discovery Scientists January 30, 2017
